Broad Institute licenses CRISPR/Cas9 tech to Transposagen
Transposagen, a Kentucky biotech that develops research tools and animal models for drug discovery, will add CRISPR technology to its existing suite of gene editing tools.
Transposagen, a Kentucky biotech that develops research tools and animal models for drug discovery, will add CRISPR technology to its existing suite of gene editing tools.